Triumvira is taking a different approach with its autologous Claudin 18.2-directed T cell therapy for gastric cancer, which is still in preclinical development.

CLDN18.2 is a transmembrane protein expressed in approximately 38% of advanced gastric cancer cases and is not generally seen in healthy tissues, making it almost completely tumour-specific ...

Dogs share our homes, our habits and sometimes, our diseases. Gastric cancer is rare in dogs, but when it does strike, it ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...

Adding durvalumab to perioperative FLOT improved EFS in patients with resectable gastric or GEJ cancer in the MATTERHORN ...

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...

(D) Cancer cells show partial membrane staining with weak (1+) intensity (arrow). (E) Gastric adenocarcinoma, biopsy from the stomach. (F) Tumor cells have complete or partial membrane staining with ...

Choi Soo-jong and Jin Tae-hyun, the representative lovers of the entertainment industry, are going on a healing trip together ...

For the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...

aBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Early Drug Development Centre, ...